Ces radiol. 2007, 61(1):68-73
Assessment of bone mineral density in hemodialysed patientsOriginal article
- 1 Radiodiagnostická klinika LF UK a FN, Plzeň-Lochotín
- 2 I. interní klinika LF UK a FN, Plzeň-Lochotín
Aim: To assess the bone mineral density in a group of hemodialysed patients and compare it with serum levels of intact parathormone, calcium, phosphorus and to evaluate its relation with coronary calcium score and duration of hemodialysis.
Method: The study was performed in a group of 72 hemodialysed patients. All patients underwent quantitative computed tomography examination of bone mineral density which was measured at the levels of lumbar vertebral bodies L1-3. Detected values of T-score were correlated with levels of intact parathormone, calcium, phosphorus, duration of hemodialysis, and calcium score. Data acquisition including assessment of coronary calcium score was performed immediately after bone mineral density anylysis.
Results: No statistically significant dependency was found between increased (p1) or decreased (p2) bone mineral density and calcium score (p1 = 0,284; p2 = 0,621), levels of phosphorus (p1 = 0,507; p2 = 0,752), calcium (p1 = 0,8; p2 = 0,895), calciumphosphorus product (p1 = 0,158; p2 = 0,731), intact parathormone (p1 = 0,906; p2 = 0,957), duration of hemodialysis (p1 = 0,160; p2 = 0,675), and presence of diabetes mellitus (p = 0,222).
Conclusion: The development of the renal osteodystrophy depends on multiple factors. No statistically significant dependency of bone mineral density was found in relation to the parameters evaluated.
Keywords: phosphorus, coronary calcium scoring, hemodialysis, bone mineral analysis, parathormone
Grants and funding:
Studie byla provedena za podpory výzkumného záměru č. MSM 0021620819.
Accepted: December 15, 2006; Published: March 1, 2007 Show citation
References
- Painter SE, Kleerekoper M, Camacho PM. Secondary osteoporosis: a review of the recent evidence. Endocr Pract 2006; 12(4): 436-445.
Go to original source...
Go to PubMed...
- Hutchison AJ, Whitehouse RW, Boulton HF, et al. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int. 1993; 44(5): 1071-1077.
Go to original source...
Go to PubMed...
- Gerakis A, Hadjidakis D, Kokkinakis E, et al. Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis. J Nephrol 2000; 13(6): 437-443.
- Jevtic V. Imaging of renal osteodystrophy. Eur J Radiol 2003; 46: 85-95.
Go to original source...
Go to PubMed...
- Zayour D, Daouk M, Medawar W, Salamoun M, et al. Predictors of Bone Mineral Density in Patients on Hemodialysis. Transplantation Proceedings 2004; 36: 1297-1301.
Go to original source...
Go to PubMed...
- Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J of Kidney Dis 2000; 36: 1115-1120.
Go to original source...
Go to PubMed...
- Iwasaki Y, Yamato H, Nii-Kono T, et al. Insufficiency of PTH action on bone in uremia. Kidney Int 2006; 102(Suppl): S34-S36.
Go to original source...
Go to PubMed...
- Buargub MA, Nabulsi, MF, Shafeh TA. Prevalence and pattern of renal osteodystrophy in chronic hemodialysis patients: a cross sectional study of 103 patients. J Kidney Dis Transpl 2006; 17(3): 401-407.
- Okuno S, Inaba M. Bone abnormalities in diabetic hemodialysis patiens. Clin Calcium 2006; 16(8): 84-90.
- Rocha LA, Riga A, Barreto FC et al. Variant of adynamic bone disease in hemodialysis patients: fact or fiction? Am J Kidney Dis 2006; 48(3): 430-436.
Go to original source...
Go to PubMed...
- Potts JT. Parathyroid hormone: past and present. Journal of Endocrinology 2005; 187: 311-325.
Go to original source...
Go to PubMed...
- Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 2006; 92(1): 39-48.
Go to original source...
Go to PubMed...
- Gallieni M, Cucciniello E, D'Amaro E, et al. Calcium, phoshate, and PTH levels in the hemodialysis population: a multicenter study. J Nephrol 2002; 15(2): 165-170.
- Coen G, Manni M, Mantella D, Splendiani G. Can cardiovascular calcifications be prevented in chronic kidney disease? G Ital Nefrol 2006; 23 (Suppl 34): S21-S25.
- Galassi A, Spiegel DM, Bellasi A, et al. Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders. Nephrol Dial Transplant. 2006; 21: 3215-3222
Go to original source...
Go to PubMed...
- Shoji T, Nishizawa Y. Effects of vitamin D on the cardiovascular system. Clin Calcium. 2006; 16(7): 23-30.
- Tsuchida T, Ishimura E, Hirowatari K, et al. Serum levels of 1-84 and 7-84 parathyroid hormone in predialysis patients with chronic renal failure measured by the intact and bio-PTH assay. Nephron Clin Pract 2006; 102(3-4): 108-114.
Go to original source...
Go to PubMed...
- Mehrotra R. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients. J Ren Nutr 2006; 16(2): 100-118.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.